1-8 of 8
Robert A. Parise
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase I Study of DMS612, a Novel Bifunctional Alkylating Agent

Leonard J. Appleman, Sanjeeve Balasubramaniam, Robert A. Parise, Christine Bryla, Christophe E. Redon, Asako J. Nakamura, William M. Bonner, John J. Wright, Richard Piekarz, David R. Kohler, Yixing Jiang, Chandra P. Belani, Julie Eiseman, Edward Chu, Jan H. Beumer, Susan E. Bates
Journal: Clinical Cancer Research
Clin Cancer Res (2015) 21 (4): 721–729.
https://doi.org/10.1158/1078-0432.CCR-14-1333
Published: 16 February 2015
View article titled, A Phase I Study of DMS612, a Novel Bifunctional Alkylating Agent
Open the PDF for A Phase I Study of DMS612, a Novel Bifunctional Alkylating Agent in another window
Includes: Supplementary data
Journal Articles

Modulation of Gemcitabine (2′,2′-Difluoro-2′-Deoxycytidine) Pharmacokinetics, Metabolism, and Bioavailability in Mice by 3,4,5,6-Tetrahydrouridine

Jan H. Beumer, Julie L. Eiseman, Robert A. Parise, Erin Joseph, Joseph M. Covey, Merrill J. Egorin
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (11): 3529–3535.
https://doi.org/10.1158/1078-0432.CCR-07-4885
Published: 02 June 2008
View article titled, Modulation of Gemcitabine (2′,2′-Difluoro-2′-Deoxycytidine) Pharmacokinetics, Metabolism, and Bioavailability in Mice by 3,4,5,6-Tetrahydrouridine
Open the PDF for Modulation of Gemcitabine (2′,2′-Difluoro-2′-Deoxycytidine) Pharmacokinetics, Metabolism, and Bioavailability in Mice by 3,4,5,6-Tetrahydrouridine in another window
Journal Articles

Plasma, Tumor, and Tissue Disposition of STEALTH Liposomal CKD-602 (S-CKD602) and Nonliposomal CKD-602 in Mice Bearing A375 Human Melanoma Xenografts

William C. Zamboni, Sandra Strychor, Erin Joseph, Dustin R. Walsh, Beth A. Zamboni, Robert A. Parise, Margaret E. Tonda, Ning Y. Yu, Charles Engbers, Julie L. Eiseman
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (23): 7217–7223.
https://doi.org/10.1158/1078-0432.CCR-07-1035
Published: 03 December 2007
View article titled, Plasma, Tumor, and Tissue Disposition of STEALTH Liposomal CKD-602 (S-CKD602) and Nonliposomal CKD-602 in Mice Bearing A375 Human Melanoma Xenografts
Open the PDF for Plasma, Tumor, and Tissue Disposition of STEALTH Liposomal CKD-602 (S-CKD602) and Nonliposomal CKD-602 in Mice Bearing A375 Human Melanoma Xenografts in another window
Journal Articles

Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies

Suresh S. Ramalingam, Robert A. Parise, Ramesh K. Ramananthan, Theodore F. Lagattuta, Lori A. Musguire, Ronald G. Stoller, Douglas M. Potter, Athanassios E. Argiris, James A. Zwiebel, Merrill J. Egorin, Chandra P. Belani
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (12): 3605–3610.
https://doi.org/10.1158/1078-0432.CCR-07-0162
Published: 15 June 2007
View article titled, Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies
Open the PDF for Phase I and Pharmacokinetic Study of Vorinostat, A Histone Deacetylase Inhibitor, in Combination with Carboplatin and Paclitaxel for Advanced Solid Malignancies in another window
Journal Articles

Pharmacokinetics, Metabolism, and Oral Bioavailability of the DNA Methyltransferase Inhibitor 5-Fluoro-2′-Deoxycytidine in Mice

Jan H. Beumer, Julie L. Eiseman, Robert A. Parise, Erin Joseph, Julianne L. Holleran, Joseph M. Covey, Merrill J. Egorin
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (24): 7483–7491.
https://doi.org/10.1158/1078-0432.CCR-06-1250
Published: 22 December 2006
View article titled, Pharmacokinetics, Metabolism, and Oral Bioavailability of the DNA Methyltransferase Inhibitor 5-Fluoro-2′-Deoxycytidine in Mice
Open the PDF for Pharmacokinetics, Metabolism, and Oral Bioavailability of the DNA Methyltransferase Inhibitor 5-Fluoro-2′-Deoxycytidine in Mice in another window
Journal Articles

Effect of the St. John's Wort Constituent Hyperforin on Docetaxel Metabolism by Human Hepatocyte Cultures

Bernard J. Komoroski, Robert A. Parise, Merrill J. Egorin, Stephen C. Strom, Raman Venkataramanan
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (19): 6972–6979.
https://doi.org/10.1158/1078-0432.CCR-04-2488
Published: 03 October 2005
View article titled, Effect of the St. John's Wort Constituent Hyperforin on Docetaxel Metabolism by Human Hepatocyte Cultures
Open the PDF for Effect of the St. John's Wort Constituent Hyperforin on Docetaxel Metabolism by Human Hepatocyte Cultures in another window
Journal Articles

Plasma Pharmacokinetics, Oral Bioavailability, and Interspecies Scaling of the DNA Methyltransferase Inhibitor, Zebularine

Julianne L. Holleran, Robert A. Parise, Erin Joseph, Julie L. Eiseman, Joseph M. Covey, Elizabeth R. Glaze, Alexander V. Lyubimov, Ya-Fei Chen, David Z. D'Argenio, Merrill J. Egorin
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (10): 3862–3868.
https://doi.org/10.1158/1078-0432.CCR-04-2406
Published: 16 May 2005
View article titled, Plasma Pharmacokinetics, Oral Bioavailability, and Interspecies Scaling of the DNA Methyltransferase Inhibitor, Zebularine
Open the PDF for Plasma Pharmacokinetics, Oral Bioavailability, and Interspecies Scaling of the DNA Methyltransferase Inhibitor, Zebularine in another window
Journal Articles

Plasma and Cerebrospinal Fluid Pharmacokinetics of Imatinib after Administration to Nonhuman Primates

Kathleen Neville, Robert A. Parise, Patrick Thompson, Alexander Aleksic, Merrill J. Egorin, Frank M. Balis, Leticia McGuffey, Cynthia McCully, Stacey L. Berg, Susan M. Blaney
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (7): 2525–2529.
https://doi.org/10.1158/1078-0432.CCR-03-0155
Published: 08 April 2004
View article titled, Plasma and Cerebrospinal Fluid Pharmacokinetics of Imatinib after Administration to Nonhuman Primates
Open the PDF for Plasma and Cerebrospinal Fluid Pharmacokinetics of Imatinib after Administration to Nonhuman Primates in another window